23-1238 Prior Authorization Changes Effective January 1, 2024
Date: 10/23/23
Get prior authorization for medical benefit drugs and services listed in this update
The below medical benefit medications require prior authorization (PA) per new HCPCS codes issued by the Centers for Medicare & Medicaid Services. This applies to the Los Angeles County Department of Health Services (LA-DHS).
Effective October 1, 2023
Code | Description | Brand/ reference |
|---|---|---|
C9155 | Injection, epcoritamab-bysp, 0.16 mg | EpkinlyTM |
C9157 | Injection, tofersen, 1 mg | QalsodyTM |
J0801 | Injection, corticotropin (Acthar Gel), up to 40 units | HP Acthar® |
J0802 | Injection, corticotropin (ANI), up to 40 units | Cortrophin® |
J0889 | Daprodustat, oral, 1 mg, (for ESRD on dialysis) | JesduvroqTM |
J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Syfovre® |
J9051 | Injection, bortezomib (MAIA), not therapeutically equivalent to J9041, 0.1 mg (prior authorization required for members ages 0-20 only) | Velcade® |
J9064 | Injection, cabazitaxel (Sandoz), not therapeutically equivalent to J9043, 1 mg | generic for Jevtana® |
J9345 | Injection, retifanlimab-dlwr, 1 mg | ZynyzTM |
PA Additions, effective January 1, 2024
View the table below for PA requirement changes.
Inpatient Services
Requirement | Comments |
|---|---|
Long-term care nursing facility admissions |
|
Additional information
If you have questions regarding the information contained in this update, contact the Health Net Medi-Cal Provider Services Center at 800-675-6110.
This information applies to Hospitals/Clinics.
For Medi-Cal, this information applies to Los Angeles (LA-DHS).